Polymed Therapeutics is an API manufacturer based in United States. It holds 2 active US drug master files and 3 valid CEPs across a filed portfolio of 4 molecules. Its filings concentrate with AIFA (IT) and EMA.
| Site | FDA FEI |
|---|---|
| Houston, United States | Not on file |
| Molecule | Regulators | Docs |
|---|---|---|
| Docetaxel | EDQM, SFDA (Saudi Arabia) | 2 |
| Paclitaxel | EDQM | 2 |
| Carfilzomib | US FDA | 1 |
| Pemetrexed | US FDA | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| AIFA (IT) | 1 | None |
| EMA | 1 | None |
Choose your molecules and target markets. Polymed Therapeutics comes back tiered against every other supplier able to file there.
Start for free